A double-blind, randomized and placebo-controlled trial of Saffron (Crocus sativus L.) in the treatment of anxiety and depression

Journal of Complementary and Integrative Medicine

Volumn 13, Issue 2, 2016, Pages 195-199

  Mazidi, Mohsen ^a,g   Shemshian, Maryam ^b   Mousavi, Seyed Hadi ^b   Norouzy, Abdolreza ^b   Kermani, Tayebe ^c   Moghiman, Toktam ^b   Sadeghi, Akram ^b   Mokhber, Naghme ^d   Ghayour Mobarhan, Majid ^b,e   Ferns, Gordon A A ^f  

^a INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c BIRJAND UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f UNIVERSITY OF BRIGHTON   (United Kingdom)

^g International College   (China)

Author keywords

anxiety; Beck Anxiety Inventory (BAI); Beck Depression Inventory (BDI); depression; saffron

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CROCUS SATIVUS EXTRACT; PLACEBO; PLANT MEDICINAL PRODUCT;

ADULT; ALTERNATIVE MEDICINE; ANXIETY DISORDER; ARTICLE; BECK ANXIETY INVENTORY; BECK DEPRESSION INVENTORY; BLOOD CELL COUNT; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; CROCUS SATIVUS; DEPRESSION; DOUBLE BLIND PROCEDURE; DSM-IV; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MENTAL PATIENT; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; THYROID FUNCTION TEST; TREATMENT DURATION; ANXIETY; CROCUS; MIDDLE AGED; PHYTOTHERAPY; PSYCHOLOGICAL RATING SCALE; TREATMENT OUTCOME;

ADULT; ANXIETY; CROCUS; DEPRESSION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT PREPARATIONS; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 84969802845     PISSN: None     EISSN: 15533840     Source Type: Journal    
DOI: 10.1515/jcim-2015-0043     Document Type: Article

References (22)

1. Akhondzadeh Basti A, Moshiri E, Noorbala AA, Jamshidi AH, Abbasi SH, Akhondzadeh S. Comparison of petal of Crocus sativus L. and fluoxetine in the treatment of depressed outpatients: a pilot double-blind randomized trial. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:439-42.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th Edition (DSM-IV). Washington, DC: American Psychiatric Association, 1994.
3. Demyttenaere K. Compliance during treatment with antidepressants. J Affect Disord 1997;43:27-39.
4. Noorbala AA, Akhondzadeh S, Tamacebi-pour N, Jamshidi AH. Hydroalcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. Ethnopharmacology 2005;97:281-4.
5. Thachil AF, Mohan R, Bhugra D. The evidence base of complementary and alternative therapies in depression. J Affect Disord 2007;97:23-35.
6. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association, 2000.
7. Antai-Otong D. Current treatment of generalized anxiety disorder. J Psychosoc Nurs Ment Health Serv 2003;41:20-9.
8. Moshiri E, Basti AA, Noorbala AA, Jamshidi AH, Hesameddin Abbasi S, Akhondzadeh S. Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial. Phytomedicine 2006;13:607-11.
9. Kermani T, Mousavi SH, Shemshian M, Norouzy A, Mazidi M, Moezzi A, et al. Saffron supplements decrease serum prooxidant-antioxidant balance in patients with metabolic syndrome: a randomized, placebo-controlled clinical trial. Avicenna J Phytomed 2015, Epub ahead of print.
10. Mazidi M, Baghban Taraghdari S, Rezaee P, Kamgar M, Jomezadeh MR, Akbarieh Hasani O, et al. The effect of hydroalcoholic extract of Cannabis Sativa on appetite hormone in rat. J Complement Integr Med 2014;11:253-7.
11. Rios JL, Recio MC, Giner RM, Manez S. An update review of saffron and its active constituents. Phytother Res 1996;10:189-93.
12. Hosseinzadeh H, Younesi H. Petal and stigma extracts of Crocus sativus L. have antinociceptive and anti-inflammatory effects in mice. BMC Pharmacol 2002;2:7.
13. Karimi G, Hosseinzadeh H, Khaleghpanah P. Study of antidepressant effect of aqueous and ethanolic extracts of Crocus sativus in mice. Iranian J Basic Med Sci 2001;4:11-15.
14. Akhondzadeh S, Tamacebi-pour N, Noorbala AA, Amini H, Fallah Pour H, Jamshidi AH, et al. Crocus sativus L. in the treatment of mild to moderate depression: a double-blind, randomized and placebo controlled trial. Phytother Res 2005;19:25-9.
15. Rezaie P, Mazidi M, Nematy M. Ghrelin, food intake, and botanical extracts: A Review. Avicenna J Phytomed 2015, Epub ahead of print.
16. Hosseinzadeh H, Noraei NB. Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in mice. Phytother Res 2009;23:768-74.
17. Beck AT, Steer RA. Beck depression inventory manual. New York: Guildford Press, 1993.
18. Judd L. Mood disorders in the general population represent an important and worldwide public health problem. Int J Clin Psychopharm 1995;10:5-10.
19. Akhondzadeh S, Fallah Pour H, Afkham K, Jamshidi AH, Khalighi-Cigarodi F. Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial. BMC Complement Altern Med 2004;4:12.
20. Georgiadou G, Tarantilis PA, Pitsikas N. Effects of the active constituents of Crocus Sativus L., crocins, in an animal model of obsessive-compulsive disorder. Neurosci Lett 2012;528:27-30.
21. Wang Y, Han T, Zhu Y, Zheng CJ, Ming QL, Rahman K, et al. Antidepressant properties of bioactive fractions from the extract of Crocus sativus L. J Nat Med 2010;64:24-30.
22. Baghban Taraghdari S, Nematy M, Mazidi M, Kamgar M, Soukhtanloo M, Hosseini M, et al. The effect of hydro-alcoholic extract of Artemisia absinthiumon appetite in male rats. Avicenna J Phytomed 2015;5:78-83.